Primer Capital

Europe, Moscow City, Russian Federation, Moscow

Description

Primer Capital is a fund investing in companies engaged in development of biotech and medical products for various pharmaceutical sectors.

Investor Profile

Primer Capital has backed more than 14 startups, with 0 new investments in the last 12 months alone. The firm has led 5 rounds, about 36% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

Concentrates on Series A, Seed, Convertible Note rounds (top funding stages).
Majority of deals are located in Russian Federation, United States, Mexico.
Strong thematic focus on Health Care, Biotechnology, Pharmaceutical.

Stage Focus

Series A (29%)
Seed (29%)
Convertible Note (14%)
Series Unknown (14%)
Pre Seed (7%)
Series B (7%)

Country Focus

Russian Federation (43%)
United States (29%)
Mexico (7%)
France (7%)
Israel (7%)
China (7%)

Industry Focus

Health Care
Biotechnology
Pharmaceutical
Medical
Biopharma
Software
Medical Device
Therapeutics
Artificial Intelligence (Ai)
Finance

FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Primer Capital frequently co-invest with?

Two Sigma Ventures

North America, New York, United States, New York

Co-Investments: 1

Gaingels

North America, Vermont, United States, Burlington

Co-Investments: 1

Trajectory Ventures

North America, New York, United States, New York

Co-Investments: 1

Homebrew

North America, California, United States, San Francisco

Co-Investments: 1

Scientific Health Development Partners

North America, Texas, United States, Dallas

Co-Investments: 1

Karman Ventures (fka Moving Capital)

North America, California, United States, Santa Monica

Co-Investments: 1

Baker & Eastlack Ventures

North America, California, United States, San Diego

Co-Investments: 1

MIT Alumni Angels of Northern California

North America, Massachusetts, United States, Cambridge

Co-Investments: 1

Crossbeam Venture Partners

North America, New York, United States, New York

Co-Investments: 1

Susa Ventures

North America, California, United States, San Francisco

Co-Investments: 1

Which angels does Primer Capital often collaborate with?

Anthony Pompliano

North America, California, United States, San Francisco

Shared Deals: 1

Gokul Rajaram

North America, California, United States, San Francisco

Shared Deals: 1

Ron Pragides

North America, California, United States, San Francisco

Shared Deals: 1

Emilie Choi

North America, California, United States, San Francisco

Shared Deals: 1

What are some of recent deals done by Primer Capital?

Nelo

Mexico City, Distrito Federal, Mexico

Nelo increases the buying power for consumers in LatAm. Backed by Two Sigma Ventures, Homebrew, Susa Ventures, and more.

FinanceFinancial ServicesFinTechInformation TechnologyMobile AppsMobile Payments

Series AOct 12, 2021

Amount Raised: $20,000,000

MatriSys Bioscience

La Jolla, California, United States

MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

Convertible NoteMar 11, 2021

Amount Raised: $3,000,000

Botkin.AI

Moscow, Moscow City, Russian Federation

Botkin.AI is a medtech startup that is developing an AI-based radiology platform.

Artificial Intelligence (AI)Health CareSoftware

Series BDec 23, 2020

Amount Raised: $2,131,770

Athira Pharma

Seattle, Washington, United States

Athira Pharma is a clinical stage drug development company that specializes in biotechnology and pharmaceutical.

BiotechnologyPharmaceuticalTherapeutics

Convertible NoteSep 4, 2020

MatriSys Bioscience

La Jolla, California, United States

MatriSys Bio is a clinical stage Specialty Biopharmaceutical Company.

BiopharmaBiotechnologyHealth CareMedicalPharmaceutical

SeedOct 8, 2018

Acticor Biotech

Paris, Ile-de-France, France

Acticor Biotech is a biopharmaceutical company developing an innovative drug for the treatment in the acute phase of ischemic stroke.

BiopharmaBiotechnologyPharmaceuticalTherapeutics

Series AJan 4, 2018

Amount Raised: $2,051,332

Gemopharm LLC

Moscow, Moscow City, Russian Federation

Gemopharm is an innovative biotech company developing a humanized monoclonal antibody platform to treat B-cell malignancies.

BiotechnologyHealth CareMedicalMedical DevicePharmaceutical

Series UnknownNov 24, 2017

MT Medicals

Hefei, Anhui, China

MT Medicals developed a highly specific inhibitor of cytochrome P450 enzymes that demonstrates high conservation.

BiotechnologyHealth CareMedicalMedical DevicePharmaceutical

Series UnknownOct 1, 2017

Bendit

Ganot, Tel Aviv, Israel

Bendit is a medical company that develops and manufactures innovative catheters based on a unique bending technology.

Health CareManufacturingMedicalMedical Device

Series ASep 3, 2017

Amount Raised: $3,550,000

Botkin.AI

Moscow, Moscow City, Russian Federation

Botkin.AI is a medtech startup that is developing an AI-based radiology platform.

Artificial Intelligence (AI)Health CareSoftware

SeedAug 2, 2017

Primer Capital

Description

Investor Profile

Investment Focus Highlights

Stage Focus

Country Focus

Industry Focus

Frequently Asked Questions

Who does Primer Capital frequently co-invest with?

Which angels does Primer Capital often collaborate with?

What are some of recent deals done by Primer Capital?

Ready to Raise Capital?

Pages

Free tools